These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21312891)
21. Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections. Bekeredjian-Ding I Front Immunol; 2020; 11():1755. PubMed ID: 32849627 [TBL] [Abstract][Full Text] [Related]
22. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy. Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E; Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364 [TBL] [Abstract][Full Text] [Related]
23. Immune Reconstitution and the Consequences for Opportunistic Infection Treatment and Prevention. Powderly WG Curr Infect Dis Rep; 1999 Apr; 1(1):99-104. PubMed ID: 11095773 [TBL] [Abstract][Full Text] [Related]
25. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients. Crow ME Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115 [TBL] [Abstract][Full Text] [Related]
26. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763 [TBL] [Abstract][Full Text] [Related]
27. Prophylaxis and treatment of infection in the bone marrow transplant recipient. Winston DJ Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916 [TBL] [Abstract][Full Text] [Related]
28. Developmental origin and sex-specific risk for infections and immune diseases later in life. Zazara DE; Arck PC Semin Immunopathol; 2019 Mar; 41(2):137-151. PubMed ID: 30298432 [TBL] [Abstract][Full Text] [Related]
31. Immune restoration disease: a consequence of dysregulated immune responses after HAART. Stone SF; Price P; French MA Curr HIV Res; 2004 Jul; 2(3):235-42. PubMed ID: 15279587 [TBL] [Abstract][Full Text] [Related]
32. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. Yang KD; Yeh WT; Yang MY; Chen RF; Shaio MF J Med Virol; 2001 Feb; 63(2):150-7. PubMed ID: 11170052 [TBL] [Abstract][Full Text] [Related]
33. Incidence of infection-associated cancers in Italy and prevention strategies. De Flora S; Crocetti E; Bonanni P; Ferro A; Vitale F; Epidemiol Prev; 2015; 39(4 Suppl 1):14-20. PubMed ID: 26499410 [TBL] [Abstract][Full Text] [Related]
34. [Clinical findings of cefoxitin in the treatment of serious infections and the prevention of postoperative infections (author's transl)]. Ito H; Uno E; Ikeda M; Shimoji T; Higashi S; Yamamoto S Jpn J Antibiot; 1981 Sep; 34(9):1307-12. PubMed ID: 7328753 [TBL] [Abstract][Full Text] [Related]
35. Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy. Willemot P; Klein MB Expert Rev Anti Infect Ther; 2004 Aug; 2(4):521-32. PubMed ID: 15482218 [TBL] [Abstract][Full Text] [Related]
36. Surgical infections in immunocompromised patients--prevention and treatment. Kusne S; Shapiro R Adv Surg; 1997; 31():299-331. PubMed ID: 9408499 [TBL] [Abstract][Full Text] [Related]
37. Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients. Roudbary M; Kumar S; Kumar A; Černáková L; Nikoomanesh F; Rodrigues CF J Fungi (Basel); 2021 Sep; 7(9):. PubMed ID: 34575758 [TBL] [Abstract][Full Text] [Related]
38. Prevention of infections in patients with neoplastic disease: use of a historical model for developmental strategies. White MH Clin Infect Dis; 1993 Nov; 17 Suppl 2():S355-8. PubMed ID: 8274600 [TBL] [Abstract][Full Text] [Related]